Epigenetic dysregulation of KCa3.1 channels induces poor prognosis in lung cancer-Reference-Cited by-同舟云学术

Epigenetic dysregulation of KCa3.1 channels induces poor prognosis in lung cancer

Published:2015-05-29 Issue:6 Volume:137 Page:1306-1317
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bulk Etmar¹,Ay Anne-Sophie²,Hammadi Mehdi²³,Ouadid-Ahidouch Halima²,Schelhaas Sonja⁴,Hascher Antje⁵,Rohde Christian⁵⁶,Thoennissen Nils H.⁵⁷,Wiewrodt Rainer⁵,Schmidt Eva⁵,Marra Alessandro⁸,Hillejan Ludger⁸,Jacobs Andreas H.⁴⁹,Klein Hans-Ulrich¹⁰,Dugas Martin¹⁰,Berdel Wolfgang E.⁵,Müller-Tidow Carsten⁵⁶,Schwab Albrecht¹

Affiliation:

1. Institute of Physiology II; University of Münster; Münster Germany

2. Laboratory of Cellular Physiology, EA 4667, SFR CAP-SANTE (FED4231), UFR Sciences; University of Picardie Jules Verne; Amiens 80039 France

3. Inserm U916; Institut Bergonié; Bordeaux 33076 France

4. European Institute for Molecular Imaging (EIMI); University of Münster; Münster Germany

5. Department of Medicine, Hematology, Oncology and Pneumology; University of Münster; Münster Germany

6. Department of Medicine, Hematology and Oncology; University Hospital of Halle (Saale); Halle (Saale) Germany

7. Department of Internal Medicine II and Clinic (Oncology Center); University Hospital Hamburg-Eppendorf; Hamburg Germany

8. Department of Thoracic Surgery; Niels-Stensen Clinics; Ostercappeln Germany

9. Department of Geriatric Medicine; Johanniter Hospital; Bonn Germany

10. Institute of Medical Informatics; University of Münster; Münster Germany

Funder

Deutsche Krebshilfe

Cells-in-Motion Cluster of Excellence

DAAD

Else-Kröner Fresenius Stiftung

Wilhelm-Sander Stiftung

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference47 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

3. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours;Goldstraw;J Thorac Oncol,2007

4. Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC;Ballas;Onco Targets Ther,2011

5. Mutational heterogeneity in cancer and the search for new cancer-associated genes;Lawrence;Nature,2013

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioelectric pharmacology of cancer: A systematic review of ion channel drugs affecting the cancer phenotype;Progress in Biophysics and Molecular Biology;2024-09

2. Synergistic Solutions: Exploring Clotrimazole’s Potential in Prostate and Bladder Cancer Cell Lines;Drugs and Drug Candidates;2024-06-28

3. Intracellular acidity impedes KCa3.1 activation by Riluzole and SKA-31;Frontiers in Pharmacology;2024-04-04

4. Kca3.1-Related Cellular Signalling Involved in Cancer Proliferation;Cellular Physiology and Biochemistry;2024-03-16

5. Targeting KCa3.1 channels to overcome erlotinib resistance in non-small cell lung cancer cells;Cell Death Discovery;2024-01-04